Desferrioxamine modulates chemically induced T helper 2-mediated autoimmunity in the rat
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
SUMMARY: A rise in interleukin (IL) 4-dependent immunoglobulin E (IgE) is a hallmark of the mercuric chloride (HgCl2)-induced Th2-mediated autoimmune syndrome in the Brown Norway (BN) rat, and one of the mediators in allergic asthma in human. Oxidative stress, a potential factor related to the pathogenesis of allergy and asthma, has been shown to up-regulate IL-4 in mast cells and predispose to degranulation in vitro. However, it remains unknown whether oxidative/antioxidative imbalance plays a role in this Th2-driven model of autoimmunity in the rat. Here we show that administration of the non-sulphydryl-containing antioxidant desferrioxamine i.p. and s.c. to BN rats reduces HgCl2-enhanced IL-4 gene expression and inhibits HgCl2-induced Th2-mediated autoimmunity. Desferrioxamine treatment suppresses significantly IgE production and lymphoproliferation, and reduces tissue injury in the form of caecal vasculitis in the HgCl2-induced autoimmune syndrome. These results support a role for oxidative stress in the pathogenesis of the HgCl2-induced Th2-dominated autoimmune syndrome. This finding might have implications for understanding the mechanisms involved in Th2 cell responses as seen in allergy and asthma and thereby aid the development of new therapeutic strategies for these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KleinJan, A., Vinke, J. G., Severijnen, L. W. F. M., & Fokkens, W. J. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15.11.x · Cited by 181
Cited by
The impact of stress on the development and expression of atopy
Wright, R. J., Cohen, R. T., & Cohen, S. (2005) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200502000-00006 · Cited by 345
The role of air pollutants in atopic dermatitis
Ahn, K. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.09.023 · Cited by 337
“An in vivo study of the mercuric chloride–induced TH2-mediated autoimmune syndrome in the Brown Norway rat revealed that antioxidant desferrioxamine treatment suppressed IL-4 gene expression.(55) These animal studies are suggestive of the possibility that oxidative stress and redox imbalance might develop or aggravate…”
BackgroundThe iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308
“Our findings are consistent with previous studies demonstrating that iron overload suppresses cell-mediated immune responses and inflammation, including production of canonical Th1 cytokines such as IFN-γ or IL-12 (29–31).”
Oxidative Stress in Atopic Dermatitis
Ji, H., & Li, X.-K. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2721469 · Cited by 215
“But the IL-4 gene expression can be suppressed by antioxidant desferrioxamine treatment [35].”
BackgroundHealy, C., Munoz-Wolf, N., Strydom, J., Faherty, L., Williams, N. C., Kenny, S., Donnelly, S. C., & Cloonan, S. M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01722-y · Cited by 78
Metadata
- Authors
- WU, Z., HOLWILL, S. D. J., & OLIVEIRA, D. B. G.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-22
- Volume
- 135
- Issue
- 2
- Pages
- 194-199
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W2041047869
- Cited by
- 25
- References
- 1
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Desferrioxamine modulates chemically induced T helper 2-mediated autoimmunity in the rat. https://app.cochat.ai/papers/10.1111/j.1365-2249.2003.02372.x
- The paper
- WU, Z., HOLWILL, S. D. J., & OLIVEIRA, D. B. G. (2004). Desferrioxamine modulates chemically induced T helper 2-mediated autoimmunity in the rat. Clinical and Experimental Immunology. https://doi.org/10.1111/j.1365-2249.2003.02372.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.